HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Quality of life independently predicts overall survival in myelofibrosis: Key insights from the COntrolled MyeloFibrosis Study with ORal Janus kinase inhibitor Treatment (COMFORT)-I study.

AuthorsHeidi E Kosiorek, Robyn M Scherber, Holly L Geyer, Srdan Verstovsek, Blake T Langlais, Gina L Mazza, Jason Gotlib, Vikas Gupta, Leslie J Padrnos, Jeanne M Palmer, Angela Fleischman, Ruben A Mesa, Amylou C Dueck
JournalBritish journal of haematology (Br J Haematol) Vol. 198 Issue 6 Pg. 1065-1068 (09 2022) ISSN: 1365-2141 [Electronic] England
PMID35751150 (Publication Type: Letter)
Chemical References
  • Janus Kinase Inhibitors
  • Nitriles
  • Protein Kinase Inhibitors
  • Janus Kinase 1
  • Janus Kinase 2
Topics
  • Humans
  • Janus Kinase 1
  • Janus Kinase 2
  • Janus Kinase Inhibitors
  • Nitriles
  • Primary Myelofibrosis (drug therapy)
  • Protein Kinase Inhibitors (therapeutic use)
  • Quality of Life

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: